Researchers will identify genes responsible for the lack of immune defenses associated with feline herpesvirus, a major cause of upper respiratory infections in cats, with the aim of developing a more effective vaccine.
Researchers will determine if common heart medications are an effective adjunct therapy for dogs with hemangiosarcoma.
Researchers will identify potential treatment targets for B-cell chronic lymphocytic leukemia in dogs and ways to identify high-risk patients.
Researchers will develop an assay to measure canine thrombopoietin (TPO), a bone marrow growth factor, to improve the diagnosis and treatment of bleeding disorders in dogs with immune platelet defects.
Researchers will evaluate the effects of additive solutions to improve blood platelet efficacy and storage for life-saving transfusion in dogs.
Researchers will evaluate an advanced imaging technique to improve the diagnosis and monitoring of spinal cord lesions associated with canine degenerative myelopathy, a spinal cord disease in dogs.
Researchers will explore metabolic drivers of cancer growth and look for new therapy targets for osteosarcoma, the most common type of bone cancer in dogs.
